Central Vein

  • XW143 - Percutaneous
    • XW1432
      • XW14325 - Transfusion Central Vein to New Technology Group 5 with Plasma, Convalescent (Nonautologous), Percutaneous Approach
    • XW1437
      • XW1437A - Transfusion Central Vein to New Technology Group 10 with Marnetegragene Autotemcel, Percutaneous Approach
    • XW143B
      • XW143B8 - Transfusion Central Vein to New Technology Group 8 with Betibeglogene Autotemcel, Percutaneous Approach
    • XW143C
      • XW143C8 - Transfusion Central Vein to New Technology Group 8 with Omidubicel, Percutaneous Approach
    • XW143D
      • XW143D7 - Transfusion Central Vein to New Technology Group 7 with High-Dose Intravenous Immune Globulin, Percutaneous Approach
    • XW143E
      • XW143E7 - Transfusion Central Vein to New Technology Group 7 with Hyperimmune Globulin, Percutaneous Approach
    • XW143F
      • XW143F8 - Transfusion Central Vein to New Technology Group 8 with OTL-103, Percutaneous Approach
    • XW143G
      • XW143G8 - Transfusion Central Vein to New Technology Group 8 with OTL-200, Percutaneous Approach
    • XW143H
      • XW143H9 - Transfusion Central Vein to New Technology Group 9 with Lovotibeglogene Autotemcel, Percutaneous Approach
    • XW143J
      • XW143J8 - Transfusion Central Vein to New Technology Group 8 with Exagamglogene Autotemcel, Percutaneous Approach